Wayne State Part of Team on Worldwide Exclusive License for Novel Approaches to Manage Cancer and Related Conditions with Green Tea Extracts
Wayne State University Division of ResearchWayne State University, along with McGill University and the Hong Kong Polytechnic University, have executed an exclusive worldwide license with Viteava Pharmaceutical Inc. for an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, (-)epigallocatechin-3-gallate (EGCG), to develop novel approaches to manage cancer and related conditions.